市場調查報告書
商品編碼
1541345
2024-2032 年營養基因組學市場報告(按產品、樣本類型、應用、最終用戶和地區)Nutrigenomics Market Report by Product, Sample Type, Application, End User, and Region 2024-2032 |
IMARC Group年,全球營養基因組市場規模達到12.126億美元。
營養基因組學,也稱為營養基因組學,是分析營養、健康和人類基因組之間關係的醫學子集。它的重點是了解基因和飲食之間的相關性及其對人體健康的影響以及癌症、心血管疾病 (CVD) 和肥胖等疾病的風險。營養基因組學有助於檢測老化和疾病易感因素,並根據基因型製定個人化飲食或營養計劃。它還有助於了解大量營養素和微量營養素的毒性和安全性,並有助於預防與飲食相關的疾病。除此之外,營養基因組學測試通常透過採集血液、口腔拭子和唾液樣本來完成。
全球肥胖盛行率不斷上升,為市場創造了積極的前景。營養基因組學有助於了解個體基因水平,根據該水平給予適當的營養飲食,進一步減少肥胖。此外,消費者對健康和健身的興趣不斷成長,以及對個人化營養產品的需求不斷增加,特別是運動員和健身愛好者,有利於市場的成長。除此之外,主要參與者正在廣泛投資於研發(R&D)活動,以利用人類遺傳學作為發現的基礎來引入創新藥物和潛在療法。他們還專注於開發客製化食品來匹配特定的基因特徵,例如增強薄弱的免疫系統和減少膽固醇化合物的攝取量,這反過來又促進了市場的成長。此外,營養缺乏症的發生率不斷增加,例如缺乏維生素D 和K、葉酸、鐵性貧血、低血鈣、骨軟化症、乾眼症、壞血病、糙皮病和佝僂病,也是另一種生長誘導因子。除此之外,大眾健康意識的提高,營養食品的消費增加以降低心臟病、糖尿病和其他慢性病的風險,以及對營養基因組測試的好處的認知不斷增強,預計將推動市場成長。
The global nutrigenomics market size reached US$ 1,212.6 Million in 2023. Looking forward, IMARC Group expects the market to reach US$ 3,049.7 Million by 2032, exhibiting a growth rate (CAGR) of 10.47% during 2024-2032.
Nutrigenomics, also known as nutritional genomics, is a subset of medical science that analyzes the relationship between nutrition, health, and the human genome. It focuses on understanding the correlation between genes and diet and their effect on a person's health and the risk of developing diseases, such as cancer, cardiovascular diseases (CVDs), and obesity. Nutrigenomics helps detect factors of aging and disease predisposition and create personalized diet or nutrition plans depending on genotype. It also assists in understanding the toxicity and safety profile of macro- and micronutrients and preventing diet-associated diseases. Besides this, nutrigenomics testing is commonly done by taking samples of blood, buccal swabs, and saliva.
The rising prevalence of obesity across the globe is creating a positive outlook for the market. Nutrigenomics helps understand the individual gene level, according to which a proper nutrition diet is given, further resulting in decreased obesity. Additionally, the growing consumer inclination toward health and fitness and the increasing demand for personalized nutrition products, especially among athletes and fitness enthusiasts, is favoring the market growth. Apart from this, key players are extensively investing in research and development (R&D) activities to introduce innovative medicine and potential cures using human genetics as a basis for discovery. They are also focusing on developing tailor-made food to match a particular gene profile, such as strengthening the weak immune system and decreasing the intake of cholesterol compounds, which, in turn, is facilitating the market growth. Moreover, the increasing incidences of nutritional deficiency disorders, such as lack of vitamins D and K, folate, iron anemia, hypocalcemia, osteomalacia, xerophthalmia, scurvy, pellagra, and rickets, are acting as another growth-inducing factor. Besides this, the rising health consciousness among the masses, increasing consumption of nutritious food to mitigate risks of heart diseases, diabetes, and other chronic diseases, and growing awareness about the benefits of nutrigenomic testing are anticipated to drive the market growth.
IMARC Group provides an analysis of the key trends in each sub-segment of the global nutrigenomics market report, along with forecasts at the global, regional and country level from 2024-2032. Our report has categorized the market based on product, sample type, application and end user.
Reagents and Kits
Services
Saliva
Buccal Swab
Blood
Others
Cardiovascular Diseases
Obesity
Cancer Research
Others
Dieticians
Sport Clinics
Corporate Programs
Others
North America
United States
Canada
Asia-Pacific
China
Japan
India
South Korea
Australia
Indonesia
Others
Europe
Germany
France
United Kingdom
Italy
Spain
Russia
Others
Latin America
Brazil
Mexico
Others
Middle East and Africa
The competitive landscape of the industry has also been examined along with the profiles of the key players being BASF SE, Cell-Logic, Cura Integrative Medicine, Danone S.A, Fagron, Genova Diagnostics, Holistic Health International, Koninklijke DSM N.V., Metagenics Inc., Nutrigenomix Inc. and Xcode Life.